Beckman Coulter Diagnostics Receives U.S. FDA Clearance for Rapid Bacterial vs. Viral Assay Providing Results in as Little as 15 Minutes for Adults and Children
BREA, Calif., Nov. 3, 2026 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced U.S. FDA clearance of the Access MeMed BV® assay, a rapid host-response blood test that helps clinicians distinguish bacterial from viral...